APAF1 and lung cancer: We demonstrated that inhibition of caspase-9 in lung cancer cells could not be attributed to abnormal expression of Apaf-1 and procaspase-9 or to genetic alterations in the procaspase-9 coding sequence analysed in NSCLC H460 cells.